Alzinova
0.73 SEK
-3.84 %
Less than 1K followers
ALZ
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-3.84 %
-9.14 %
-12.42 %
-47.54 %
-45.82 %
-75.14 %
-79.86 %
-86.87 %
-89.88 %
Alzinova is a biotechnology company. The company specializes in the therapeutic treatment of Alzheimer's and conducts research and development of peptides that are further developed as vaccines. In addition, the company also develops various research tools within the field of work. The largest operations are found in the Nordic market. The company was founded in 2011 and has its headquarters in Mölndal.
Read moreMarket cap
121.18M SEK
Turnover
129.98K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
25/3
2026
Annual report '25
14/5
2026
Interim report Q1'26
26/5
2026
General meeting '26
All
Press releases
3rd party
ShowingAll content types
The subscription period in Alzinovas rights issue of units starts today
Alzinova offentliggör prospekt med anledning av företrädesemission av units
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools